A study listed on ClinicalTrials.gov.

Recruiting now. Registry record last updated April 23, 2026.

Who can join: Adults 18 to 80, have obesity or are overweight, BMI 27+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The full study runs about 2 years.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor Ian J. Neeland, MDDrug investigational drugClass OtherSites 1 USEnrollment target 64

What this study is for

Primary condition: Dietary Change. Also studied in: Obesity & Overweight, Food Acceptance.

Full scientific study title: Dietary Peanuts and Nutrition-Related Outcomes.

Who can join

Age18 to 80SexAnyBMI27 or higher

Adults 18 to 80, have obesity or are overweight, BMI 27+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months

Key exclusion criteria

No use or contraindication to use of a GLP-1 RA
Known allergy to nuts
Pregnant or breastfeeding
Incarcerated

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Ohio1 site

University Hospitals Cleveland Medical Center
Clevland, Ohio
Ian Neeland, MD216-844-5965Ian.Neeland@UHhospitals.org

Follow this trial

We email you if NCT07244458 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: April 20, 2026. Expected completion: December 2027. Last updated on ClinicalTrials.gov: April 23, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.